Slide 1: Owlet, Inc. Investor Presentation
Owlet, Inc. (NYSE: OWLT) Investor Presentation March 4, 2025 Fall 2025
Slide 2: Disclaimer
2025 Confidential | 2 Disclaimer About this Presentation This presentation shall not constitute an offer to sell or a solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such an offer, solicitation or sale is no
Slide 3: Owlet's Experienced Team
2025 Confidential | 3 Owletʼs Experienced Team Jonathan Harris Kurt Workman Amanda Twede Jennifer Billington CEO & President Executive Chairman Crawford Chief Revenue Officer & Co-Founder Chief Financial Officer David Kizer Burc Sahinoglu Elizabeth Teran Jay Gentzkow Chief Operating Officer Chief Te
Slide 4: Owlet Case Study: Customer Testimonial
2025 Confidential | 4 Owlet Case Study: Customer Testimonial Only Owlet: Critical Care “My daughter Katherine had been lethargic and not feeding well throughout the day. I didnʼt think much of it as we all know babies can be temperamental. I put her Owlet Dream Sock on her like I always do. Within t
Slide 5: Wholistic Health Platform: Arming Parents with Data and Insights
2025 Confidential | 5 Wholistic Health Platform: Arming Parents with Data and Insights Safety Sleep Health
Slide 6: Owlet is Building the World's Largest Pediatric Health Platform
2025 Confidential | 6 Owlet is Building the Worldʼs Largest Pediatric Health Platform The Owlet Advantage Existing Wearable Players iRhythm Apple Oura Zio Patch + Watch + Ring + Patient Data Health Data Health Data Dream Sock + Health Data = Trusted Pediatric Care Cardiac Health Personal Health Pers
Slide 7: The Leading Pediatric Health Platform with Significant Differentiation in the Nursery Ecosystem
2025 Confidential | 7 | The Leading Pediatric Health Platform with Significant Differentiation in the Nursery Ecosystem #1 Brand in Significant Market Largest & Most Pediatric Health Differentiation Engaged Infant Community First #1 71 2 6 63 150M+ 2M+ 1.4M & Only Product FDA International Patents Baby
Slide 8: We've built an amazing, trusted brand.
2025 Confidential | 8 Weʼve built an amazing, trusted brand.
Slide 9: Owlet meets parents on night one.
2025 Confidential | 9 Owlet meets parents on night one. When that first wave of doubt or fear sets in. Weʼre there in the quiet hours of the night, providing real-time insight and a sense of calm.
Slide 10: There is power in being first.
2025 Confidential | 10 There is power in being first. Weʼre not just offering a product — weʼre offering peace of mind at a time when everything feels fragile. And in doing that, we earn the right to become more than a product. We become a trusted partner.
Slide 11: Owlet Provides Support and Insights to Alleviate Parents' Concerns
2025 Confidential | 11 Owlet Provides Support and Insights to Alleviate Parents' Concerns Safety Sickness Sleep Assurance Are they breathing? When should I call my Will we ever sleep Is this normal for my doctor? again? baby? SIDS: #1 cause of infant Respiratory: #1 cause of Lost Sleep: A primary co
Slide 12: Owlet's Dream Sock is the first and only medically cleared, over-the-counter monitor
2025 Confidential | 12 Owletʼs Dream Sock is the first and only medically cleared, over-the-counter monitor for pediatric healthcare at home(1) (1) Only medically cleared monitor currently available on the market. US FDA clearance (de novo), CE marked, UKCA marked, Australia and New Zealand cleared,
Slide 13: We Are on the Brink of a Transformative Pediatric Health Opportunity
2025 Confidential | 13 | We Are on the Brink of a Transformative Pediatric Health Opportunity Monetize Expand Deeper Into Data and Growing High-Margin Healthcare with Insights Extend LTV Owlet is the leading pediatric health Subscription Beyond Infants Reimbursement platform, primed to capitalize on
Slide 14: Opportunity to Expand our Support Beyond the Infant Journey
2025 Confidential | 14 Opportunity to Expand our Support Beyond the Infant Journey While the parenting journey is expansive, our immediate focus should prioritize the early years, specifically across Sleep, Health, and Safety. Owletʼs LTV Expansion Opportunity Owlet Today Family Planning Infancy & E
Slide 15: Pediatric Data Flywheel Enhancing Owlet's Offering Platform
2025 Confidential | 15 Pediatric Data Flywheel Enhancing Owletʼs Offering Platform Owletʼs Data Flywheel Interconnected Ecosystem of Products Stronger Better Differentiation Products Clinical More Insights Products Purchased Continually Improving Algorithm More Stronger Predictive Insights and Alerts
Slide 16: First and Only FDA-Cleared Pediatric Health Monitor with Significant Barriers to Entry
2025 Confidential | 16 First and Only FDA-Cleared Pediatric Health Monitor on the Market with Significant Barriers to Entry With years of effort & significant investment, Owlet meets rigorous standards for clinical efficacy and safety with FDA clearance
Slide 17: Global Regulatory Clearances Unlock New Markets
2025 Confidential | 17 Global Regulatory Clearances Unlock New Markets Expanding penetration in current regulatory approved countries, while targeting clearances in many new countries US UK EU Australia + New South Africa India FDA-Cleared CA-Marked CE-Marked Zealand SAHPRA-Cleared CSAHPRA- ARTG-Cle
Slide 18: Owlet's Operating at the Center of Several Large and Growing Markets
2025 Confidential | 18 Owletʼs Operating at the Center of Several Large and Growing Markets Smart Baby Monitors ~$2B Pediatric Health Costs, Annual, U.S. ~$30B Smart Wearables ~$110B Telehealth ~$160B Note: See Appendix for sources and notes. Owlet is in the early stages of establishing its addressa
Slide 19: Owlet's Connected Ecosystem Enables Expansion Opportunities
2025 Confidential | 19 Owletʼs Connected Ecosystem Enables Expansion Opportunities FDA Expand LTV Health Clearance Registry Owlet Data Platform New Countries A Sock On Every Baby 18+ Month = Together, we aim to build the worldʼs largest pediatric health and data platform Owlet Owlet360 OnCall New Pl
Slide 20: Owlet's Multi-Dimensioned Growth Strategy
2025 Confidential | 20 Owletʼs Multi-Dimensioned Growth Strategy Core Domestic International Owlet360 Healthcare Growth Growth Subscription Expansion ● Continued execution on core ● New regulatory clearances and ● Owlet360 unlocking and ● Long-term opportunity for domestic product growth certificati
Slide 21: Financial Highlights | LTM Q3 2025
2025 Confidential | 21 Financial Highlights | LTM Q3 2025 Revenue Gross Margin Adj. EBITDA ● $99.6M LTM Q3ʼ25 revenue ● 52.1% LTM Q3ʼ25 gross margin ● $2.4M LTM Q3ʼ25 adj. EBITDA ● 26.8% growth y/y ● 340 bps expansion y/y ● Six consecutive quarters of adj. EBITDA profitability $ in millions $ in mil
Slide 22: Best-in-Class Operating Metrics
2025 Confidential | 22 Best-in-Class Operating Metrics Non-GAAP Contribution Margin(1) vs. Operating Expense Trend LTV / CAC(2) $ in millions 4.8 LTM Q3 2025 Revenue / FTE(3) $1.1M LTM Q3 2025 (1) Non-GAAP contribution margin = gross profit minus sales and marketing expenses (excluding sales and mar
Slide 23: We Are on the Brink of a Transformative Pediatric Health Opportunity
2025 Confidential | 23 | We Are on the Brink of a Transformative Pediatric Health Opportunity Monetize Expand Deeper Into Data and Growing High-Margin Healthcare with Insights Extend LTV Owlet is the leading pediatric health Subscription Beyond Infants Reimbursement platform, primed to capitalize on
Slide 24: Owlet is Building the World's Largest Pediatric Health Platform
2025 Confidential | 24 Owlet is Building the Worldʼs Largest Pediatric Health Platform
Slide 25: Appendix
2025 Confidential | 25 Appendix
Slide 26: Appendix
2025 Confidential | 26 Appendix ● #1 Baby Monitor: Circana, U.S. Store Level Enabled Tracking Service, Baby Monitors, #1 based on dollar share, 6-month and 12-month trailing August 2025. ● 71 Product NPS Score: Owlet Survey, two-week blended NPS, 10/14/2025, 1,900+ respondents; Dream Sock NPS = 77.
Slide 27: Non-GAAP Adjusted EBITDA Reconciliation
2025 Confidential | 27 Non-GAAP Adjusted EBITDA Reconciliation $ in thousands
Slide 28: Non-GAAP Contribution Margin Reconciliation
2025 Confidential | 28 Non-GAAP Contribution Margin Reconciliation $ in thousands
Slide 29: Thank You
2025 Confidential | 29 Thank You